Answers are grounded in this paper and cite their sources.
Observational study demonstrates FLASH radiotherapy protects normal lung tissue while impacting tumors, suggesting advancements for cancer treatment.
FLASH radiotherapy (FLASH-RT), with its ultra-high dose rate (≥40 Gy/s) that causes the "FLASH effect," significantly reduces normal tissue toxicity while maintaining tumor cytotoxicity, but its molecular mechanisms have not been fully elucidated. Previous studies have identified a protective mitochondrial homeostasis mechanism in normal cells during proton FLASH-RT. To further investigate this mechanism, we used an orthotopic lung cancer mouse model to compare the effects of FLASH-RT with conventional radiotherapy and employed single-cell sequencing to comprehensively analyze differences in single-cell gene expression profiles between normal lung tissue and tumors after irradiation. The results indicate that FLASH-RT protects normal lung tissue by regulating the immune microenvironment, inhibiting oxidative stress, reducing epithelial cell apoptosis, and maintaining mitochondrial function. In tumors, a differential molecular response occurs, involving activation of autophagy/apoptosis pathways, enhancement of cellular stress responses, disruption of mitochondrial homeostasis to reduce ATP production, and regulation of the PI3K/Akt signaling pathway to induce cell cycle arrest and apoptosis. This work reveals the molecular mechanisms of FLASH-RT, providing a theoretical basis for its clinical application and advancing precision radiotherapy for cancer.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: